홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /화합물

Levalbuterol Hydrochloride

HCID 123601
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
50293-90-8
표준 SMILES
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl
InChIKey
OWNWYCOLFIFTLK-YDALLXLXSA-N
분자식
C13H22ClNO3
평균 분자량
275.77 g/mol
단동위원소 질량
275.12882124

개요

Levalbuterol Hydrochloride is the hydrochloride salt form of levalbuterol, a relatively selective sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol hydrochloride binds to beta-2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, thereby increasing the production of cyclic-3', 5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cyclic AMP concentrations also inhibit the release of inflammatory mediators from mast cells.

이름 및 식별자

우선 이름
Levalbuterol Hydrochloride
IUPAC
4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;hydrochloride
영어명
alfa1-[[1,1-Dimethylethylamino]methyl]-4-hydroxy-1-(S),3-benzene dimethanol Hydrochlorid
분자식
C13H22ClNO3
분자량
275.77168

이름 및 동의어

Levalbuterol hydrochloride50293-90-8Levalbuterol HClXopenexLevosalbutamol Hydrochloride(-)-Salbutamol hydrochlorideAlbuterol hydrochloride, r-WDQ1526QJMNSC-759255Albuterol (r)-form hydrochlorideDTXSID20198296RefChem:56699
이름 더 보기
ZopenexUnii-wdq1526qjmSalbutamol HydrochlorideSalbutamol (R)-Isomer HClSalbutamol Impurity 8 HClSalbutamol Impurity 14 HCl
Levalbuterol Inhalation SolutionDTXCID501207871,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, Hydrochloride,(alpha1R)-(R)-Albuterol Hydrochloride(R)-Salbutamol hydrochlorideSalbutamol (hydrochloride)R-albuterol hydrochloride(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hydrochloride

데이터베이스 식별자

CAS
50293-90-8
PubChem CID
123601

물성

구조 계산 물성

극성 표면적
72.7 Ų
수소 결합 공여자 수
5
수소 결합 수용자 수
4
회전 가능 결합 수
5
무거운 원자 수
18
형식 전하
0
복잡도
227

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section158.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
169 · 169-171°C
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: ≥15mg/mL
물리적 상태
가루
색상
흰색에서 황갈색까지
수용성
2 O: · H2O: ≥15mg/mL
InChI
InChI=1/C13H21NO3.ClH/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-6,12,14-17H,7-8H2,1-3H3;1H/t12-;/s3
InChIKey
OWNWYCOLFIFTLK-ZLBVLXFENA-N
SMILES
c1(CO)cc([C@@H](O)CNC(C)(C)C)ccc1O.Cl |&1:5,r|

화학적 성질

Off-White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Exposure RoutesSystemic absorption is rapid following aerosol administration.
Toxicity Summary · 1건

Salbutamol is a beta(2)-adrenergic agonist and thus it stimulates beta(2)-adrenergic receptors. Binding of albuterol to beta(2)-receptors in the lungs results in relaxation of bronchial smooth muscles. It is believed that salbutamol increases cAMP production by activating adenylate cyclase, and the actions of salbutamol are mediated by cAMP. Increased intracellular cyclic AMP increases the activity of cAMP-dependent protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations. A lowered intracellular calcium concentration leads to a smooth muscle relaxation and bronchodilation. In addition to bronchodilation, salbutamol inhibits the release of bronchoconstricting agents from mast cells, inhibits microvascular leakage, and enhances mucociliary clearance.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataLD<sub>50</sub>=1100 mg/kg (orally in mice)

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Hydrolyzed by esterases in tissue and blood to the active compound colterol. The drug is also conjugatively metabolized to salbutamol 4'-O-sulfate. Route of Elimination: Approximately 72% of the inhaled dose is excreted in the urine within 24 hours, 28% as unchanged drug and 44% as metabolite. Half Life: 1.6 hours

FDA Pharmacological Classification · 4건

LEVALBUTEROL HYDROCHLORIDE

beta2-Adrenergic Agonist [EPC]; Adrenergic beta2-Agonists [MoA]

LEVALBUTEROL INHALATION SOLUTION

Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]

용도 및 제조

UsesFor symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD.
응용 분야 · 2건

개요Salbutamol is an agonist of the β2-adrenergic receptor (β2-AR; Kd = 759 nM in a radioligand binding assay using CHO cells expressing the human receptor). It is selective for β2-ARs over β1- and β3-ARs (Kds = 46.8 and 21.9 μM, respectively). Salbutamol (25-50 μg/kg, i.v.) reduces acetylcholine-induced bronchospasm in anesthetized guinea pigs. It also reduces response of bronchial muscle to efferent vagal stimulation in anesthetized cats and dogs when administered at doses ranging from 1 to 2.5 and 10 to 20 μg/kg, respectively. Nebulized salbutamol reduces transpulmonary pressure in recurrent airway obstruction-affected horses (EC50 = 39.7 μg). Formulations containing salbutamol have been used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

용도The R-enantiomer

상·하류 제품 정보

상류 원료

3차-뷰틸아민

관련 반응

4건
반응 기록 만들기
HRID 1078016 반응식
HRID 1078016생성물로uspto-grants-1996_08
HRID 1455721 반응식
HRID 1455721생성물로반응물로uspto-grants-2009_01
HRID 2375770 반응식
HRID 2375770반응물로uspto-grants-2008_12
HRID 2375771 반응식
HRID 2375771반응물로uspto-grants-2008_12

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
DTXSID
DTXSID20198296
ChEMBL
CHEMBL1201061
UNII
WDQ1526QJM
EC Number
627-135-3

안전 데이터

wgk
3
HS 번호
2922504500
risk_code
22-37/38-41
hazard_code
Xn
safety_code
26-39
Hazard Classifications
Acute Tox. 4 OralEye Dam. 1Skin Irrit. 2STOT SE 3
스토리지 클래스
11 - Combustible Solids
브롬화수소
Methyl 5-acetylsalicylate
디메틸설파이드보란
Palladium hydroxide